Surface modification of polydimethylsiloxane with a covalent antithrombin–heparin complex to prevent thrombosis

References

• Brash JL. Exploiting the current paradigm of blood–material interactions for the rational design of blood-compatible materials. J. Biomater. Sci., Polym. Ed. 2000;11:1135–1146.
   PubMed Web of Science ®Google Scholar
• Pinto S, Alves P, Matos CM, Santos AC, Rodrigues LR, Teixeira JA, Gil MH. Poly(dimethyl siloxane) surface modification by low pressure plasma to improve its characteristics towards biomedical applications. Colloids Surf., B. 2010;81:20–26.
   PubMed Web of Science ®Google Scholar
• Brash JL. Hydrophobic polymer surfaces and their interactions with blood. Ann. N.Y. Acad. Sci. 1977;283:356–371.
   Web of Science ®Google Scholar
• Chen H, Chen Y, Sheardown H, Brook MA. Immobilization of heparin on a silicone surface through a heterobifunctional PEG spacer. Biomaterials. 2005;26:7418–7424.
   PubMed Web of Science ®Google Scholar
• Chen H, Brook MA, Sheardown H. Silicone elastomers for reduced protein adsorption. Biomaterials. 2004;25:2273–2282.
   PubMed Web of Science ®Google Scholar
• Abbasi F, Mirzadeh H, Katbab A-A. Modification of polysiloxane polymers for biomedical applications: a review. Polym. Int. 2001;50:1279–1287.
   Web of Science ®Google Scholar
• Mikhail AS, Ranger JJ, Liu L, Longenecker R. Rapid and efficient assembly of functional silicone surfaces protected by PEG: cell adhesion to peptide-modified PDMS. J. Biomater. Sci., Polym. Ed. 2010;21:821–842.
   PubMed Web of Science ®Google Scholar
• Farrell M, Beaudoin S. Surface forces and protein adsorption on dextran- and polyethylene glycol-modified polydimethylsiloxane. Colloids Surf., B. 2010;81:468–475.
   PubMed Web of Science ®Google Scholar
• Zhou J, Yan H, Ren K, Dai W, Wu H. Convenient method for modifying poly(dimethylsiloxane) with poly(ethylene glycol) in microfluidics. Anal. Chem. 2009;81:6627–6632.
   Google Scholar
• Olsson P, Sanchez J, Mollnes TE. On the blood compatibility of end-point immobilized heparin. J. Biomater. Sci., Polym. Ed. 2000;11:1261–1273.
   PubMed Web of Science ®Google Scholar
• Gott VL, Daggett RL. Serendipity and the development of heparin and carbon surfaces. Ann Thorac Surg. 1999;68:S19–S22.
   PubMed Web of Science ®Google Scholar
• Øvrum E, Tangen G, Tølløfsrud S, Skeie B, Ringdal MAL, Istad R, Øystese R. Heparinized cardiopulmonary bypass circuits and low systemic anticoagulation: an analysis of nearly 6000 patients undergoing coronary artery bypass grafting. J. Thorac. Cardiovasc. Surg. 2011;141:1145–1149.
   Google Scholar
• Patel S, Berry L, Chan A. Covalent antithrombin–heparin complexes. Thromb. Res. 2007;120:151–160.
   Google Scholar
• Sask KN, Berry L, Chan A, Brash JL. Modification of polyurethane surface with an antithrombin–heparin complex for blood contact: influence of molecular weight of polyethylene oxide used as a linker/spacer. Langmuir. 2012;28:2099–2106.
   PubMed Web of Science ®Google Scholar
• Sask KN, Zhitomirsky I, Berry L, Chan A, Brash JL. Surface modification with an antithrombin–heparin complex for anticoagulation: studies on a model surface with gold as substrate. Acta Biomater. 2010;6:2911–2919.
   PubMedGoogle Scholar
• Wu W, Rochow N, Fusch G, Kusdaya R, Choi A, Selvaganapathy PR, Fusch C. Development of microfluidic oxygenators as lung assisting devices for preterm infants. The 15th International Conference on Miniaturized Systems for Chemistry and Life Sciences; 2011; Seattle, WA; p. 550–552.
   Google Scholar
• Rochow N, Wu W, Chan E, Nagpal D, Fusch G, Selvaganapathy P, Monkman S, Fusch C. Integrated microfluidic oxygenator bundles for blood gas exchange in premature infants. IEEE 25th International Conference on Micro Electro Mechanical Systems; 2012; p. 957–960.
   Google Scholar
• Tan J, Brash JL. Nonfouling biomaterials based on polyethylene oxide-containing amphiphilic triblock copolymers as surface modifying additives: adsorption of proteins from human plasma to copolymer/polyurethane blends. J. Biomed. Mater. Res. Part A. 2009;90A:196–204.
   Google Scholar
• Atkinson HM, Mewhort-Buist TA, Berry L, Chan A. Anticoagulant mechanisms of covalent antithrombin–heparin investigated by thrombelastography. Comparison with unfractionated heparin and low-molecular-weight heparin. Thromb. Haemost. 2009;102:626–628.
   Google Scholar
• Mewhort-Buist TA, Junop M, Berry L, Chindemi P, Chan A. Structural effects of a covalent linkage between antithrombin and heparin: covalent N-terminus attachment of heparin enhances the maintenance of antithrombin’s activated state. J. Biochem. 2006;140:175–184.
   Google Scholar
• Paredes N, Wang A, Berry L, Smith LJ, Stafford AR, Weitz JI, Chan A. Mechanisms responsible for catalysis of the inhibition of factor Xa or thrombin by antithrombin using a covalent antithrombin–heparin complex. J. Biol. Chem. 2003;278:23398–23409.
   Google Scholar
• Berry L, Stafford A, Fredenburgh J, O’Brodovich H, Mitchell L, Weitz J, Andrew M, Chan A. Investigation of the anticoagulant mechanisms of a covalent antithrombin–heparin complex. J. Biol. Chem. 1998;273:34730–34736.
   PubMed Web of Science ®Google Scholar
• Chen H, Zhang Z, Chen Y, Brook MA, Sheardown H. Protein repellant silicone surfaces by covalent immobilization of poly(ethylene oxide). Biomaterials. 2005;26:2391–2399.
   PubMed Web of Science ®Google Scholar
• Chen H, Brook MA, Sheardown H, Chen Y, Klenkler BJ. Generic bioaffinity silicone surfaces. Bioconjug. Chem. 2006;17:21–28.
   PubMedGoogle Scholar
• Chen H, Wang L, Zhang Y, Li D, McClung WG, Brook MA, Sheardown H, Brash JL. Fibrinolytic poly(dimethyl siloxane) surfaces. Macromol. Biosci. 2008;8:863–870.
   PubMed Web of Science ®Google Scholar
• Chen H, Zhang Y, Li D, Hu X, Wang L, McClung WG, Brash JL. Surfaces having dual fibrinolytic and protein resistant properties by immobilization of lysine on polyurethane through a PEG spacer. J. Biomed. Mater. Res. Part A. 2009;90A:940–946.
   Web of Science ®Google Scholar
• Merrett K, Cornelius RM, McClung WG, Unsworth LD. Surface analysis methods for characterizing polymeric biomaterials. J. Biomater. Sci., Polym. Ed. 2002;13:593–621.
   PubMed Web of Science ®Google Scholar
• Knight LC, Olexa SA, Malmud LS, Budzynski AZ. Specific uptake of radioiodinated fragment E1 by venous thrombi in pigs. J. Clin. Invest. 1983;72:2007–2013.
   Google Scholar
• Du YJ, Cornelius RM, Brash JL. Measurement of protein adsorption to gold surface by radioiodination methods: suppression of free iodide sorption. Colloids Surf., B. 2000;17:59–67.
   Web of Science ®Google Scholar
• Cornelius RM, Archambault J, Berry L, Chan A, Brash JL. Adsorption of proteins from infant and adult plasma to biomaterial surfaces. J. Biomed. Mater. Res. 2002;60:622–632.
   PubMedGoogle Scholar
• Du YJ, Klement P, Berry L, Tressel P, Chan A. In vivo rabbit acute model tests of polyurethane catheters coated with a novel antithrombin–heparin covalent complex. Thromb. Haemost. 2005;94:366–372.
   PubMed Web of Science ®Google Scholar
• Li D, Chen H, McClung WG, Brash JL. Lysine-PEG-modified polyurethane as a fibrinolytic surface: effect of PEG chain length on protein interactions, platelet interactions and clot lysis. Acta Biomater. 2009;5:1864–1871.
   PubMed Web of Science ®Google Scholar
• Alibeik S, Zhu S, Yau JW, Weitz JI, Brash JL. Dual surface modification with PEG and corn trypsin inhibitor: effect of PEG:CTI ratio on protein resistance and anticoagulant properties. J. Biomed. Mater. Res. Part A. 2012;100A:856–862.
   Google Scholar
• Berry L, Becker DL, Chan A. Inhibition of fibrin-bound thrombin by a covalent antithrombin–heparin complex. J. Biochem. 2002;132:167–176.
   Google Scholar
• Chan A, Berry L, Brodovich HO, Klement P, Mitchell L, Baranowski B, Monagle P, Andrew M. Covalent antithrombin–heparin complexes with high anticoagulant activity. Intravenous, subcutaneous, and intratracheal administration. J. Biol. Chem. 1997;272:22111–22117.
   PubMed Web of Science ®Google Scholar
• Tsai W-B, Grunkemeier JM, McFarland CD, Horbett TA. Platelet adhesion to polystyrene-based surfaces preadsorbed with plasmas selectively depleted in fibrinogen, fibronectin, vitronectin, or von Willebrand’s factor. J. Biomed. Mater. Res. 2002;60:348–359.
   PubMed Web of Science ®Google Scholar
• Berry L, Chan A. Improving blood compatibility. In: Chu P, Liu X, editors. Biomaterials fabrication and processing handbook. Boca Raton (FL): CRC Press; 2007. p. 535–573.
   Google Scholar
• Bick RL, Frenkel EP, Walenga J, Fareed J, Hoppensteadt DA. Unfractionated heparin, low molecular weight heparins, and pentasaccharide: basic mechanism of actions, pharmacology, and clinical use. Hematol. Oncol. Clin. North Am. 2005;19:1–51.
   PubMed Web of Science ®Google Scholar
• Conard J, Brosstad F, Larsen M, Samama M, Abildgaard U. Molar antithrombin concentration in normal human plasma. Haemostasis. 1983;13:363–368.
   PubMedGoogle Scholar
• Jahns G, Haeffner-Cavaillon N, Nydegger U, Kazatchkine M. Complement activation and cytokine production as consequences of immunological bioincompatibility of extracorporeal circuits. Clin. Mater. 1993;14:303–336.
   PubMedGoogle Scholar
• Reikvam H, Steien E, Hauge B, Liseth K, Hagen KG, Størkson R, Hervig T. Thrombelastography. Transfus. Apher. Sci. 2009;40:119–123.
   PubMed Web of Science ®Google Scholar
• Peng HT. Thromboelastographic study of biomaterials. J. Biomed. Mater. Res. Part B. 2010;94B:469–485.
   Google Scholar
• Shankarraman V, Davis-Gorman G, Copeland JG, Caplan MR, McDonagh PF. Standardized methods to quantify thrombogenicity of blood-contacting materials via thromboelastography. J. Biomed. Mater. Res. Part B. 2012;100B:230–238.
   Google Scholar